Company Data
Moleculin Biotech Inc.
Ticker
MBRX
Current Price
$2.27 -4.62%
Market Cap
$6.1M
Price Target
Refer to Report
Volume
139.7K
52wk Range
$2.25 - $33
Overview
Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis.